How is Abilifysupplied?

Dosage Forms And Strengths ABILIFY®(aripiprazole) Tablets are available as described in Table 2. Table 2: ABILIFY Tablet Presentations
Tablet Strength Tablet Color/Shape Tablet Markings 2 mg green “A-006” modified rectangle and “2” 5 mg blue “A-007” modified rectangle and “5” 10 mg pink “A-008” modified rectangle and “10” 15 mg yellow “A-009” round and “15” 20 mg white “A-010” round and “20” 30 mg pink “A-011” round and “30” ABILIFY DISCMELT®(aripiprazole) Orally Disintegrating Tablets are available as described in Table 3. Table 3: ABILIFY DISCMELT Orally Disintegrating Tablet Presentations
Tablet Strength Tablet Color/Shape Tablet Markings 10 mg pink (with scattered specks) round “A” and “640” “10” 15 mg yellow (with scattered specks) round “A” and “641” “15” ABILIFY®(aripiprazole) Oral Solution (1 mg/mL) is a clear, colorless to light-yellow solution, supplied in child-resistant bottles along with a calibrated oral dosing cup. ABILIFY® (aripiprazole) Injection for Intramuscular Use is a clear, colorless solution available as a ready-to-use, 9.75 mg/1.3 mL (7.5 mg/mL) solution in clear, Type 1 glass vials. Storage And Handling ABILIFY® (aripiprazole) Tablets have markings on one side and are available in the strengths and packages listed in Table 22. Table 22: ABILIFY Tablet Presentations
Tablet Strength Tablet Color/Shape Tablet Markings Pack Size NDC Code 2 mg green modified rectangle “A-006” and “2” Bottle of 30 59148-006-13 5 mg blue “A-007” Bottle of 30 59148-007-13   modified rectangle and “5” Blister of 100 59148-007-35 10 mg pink “A-008” Bottle of 30 59148-008-13   modified rectangle and “10” Blister of 100 59148-008-35 15 mg yellow “A-009” Bottle of 30 59148-009-13   round and “15” Blister of 100 59148-009-35 20 mg white “A-010” Bottle of 30 59148-010-13   round and “20” Blister of 100 59148-010-35 30 mg pink “A-011” Bottle of 30 59148-011-13   round and “30” Blister of 100 59148-011-35 ABILIFY DISCMELT® (aripiprazole) Orally Disintegrating Tablets are round tablets with markings on either side. ABILIFY DISCMELT is available in the strengths and packages listed in Table 23. Table 23: ABILIFY DISCMELT Orally Disintegrating Tablet Presentations
Tablet Strength Tablet Color Tablet Markings Pack Size NDC Code 10 mg pink (with scattered specks) “A” and “640” “10” Blister of 30 59148-640-23 15 mg yellow (with scattered specks) “A” and “641” “15” Blister of 30 59148-641-23 ABILIFY® (aripiprazole) Oral Solution (1 mg/mL) is supplied in child-resistant bottles along with a calibrated oral dosing cup. ABILIFY Oral Solution is available as follows: 150 mL bottle NDC 59148-013-15 ABILIFY® (aripiprazole) Injection for intramuscular use is available as a ready-to-use, 9.75 mg/1.3 mL (7.5 mg/mL) solution in clear, Type 1 glass vials as follows: 9.75 mg/1.3 mL single-dose vial NDC 59148-016-65 Storage Tablets Store at 25°C(77°F); excursions permitted between 15°C to 30°C(59°Fto 86°F) [see USP Controlled Room Temperature]. Oral Solution Store at 25°C (77°F); excursions permitted between 15°C to 30°C(59°F to 86°F) [see USP Controlled Room Temperature]. Opened bottles of ABILIFY Oral Solution can be used for up to 6 months after opening, but not beyond the expiration date on the bottle. The bottle and its contents should be discarded after the expiration date. Injection Store at 25°C (77°F); excursions permitted between 15°C to 30°C(59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light by storing in the original container. Retain in carton until time of use. Tablets manufactured by Otsuka Pharmaceutical Co., Ltd., Tokyo, 101-8535 Japan or Bristol-Myers Squibb Company, Princeton, NJ 08543 USA. Orally Disintegrating Tablets, Oral Solution, and Injection manufactured by Bristol-Myers Squibb Company, Princeton, NJ 08543 USA. Distributed and marketed by Otsuka America Pharmaceutical, Inc., Rockville, MD 20850 USA. Distributed and marketed by Otsuka America Pharmaceutical, Inc., Rockville, MD 20850 USA. Last reviewed on RxList: 6/19/2014
This monograph has been modified to include the generic and brand name in many instances.

Source: http://www.rxlist.com